The Market Reports

Index

1 Human Insulin Drugs Market Overview
1.1 Product Overview and Scope of Human Insulin Drugs
1.2 Human Insulin Drugs Segment by Type
1.2.1 Global Human Insulin Drugs Sales Growth Rate Comparison by Type (2022-2028)
1.2.2 Basal or Long-acting Insulins
1.2.3 Bolus or Fast-acting Insulins
1.2.4 Traditional Human Insulins
1.2.5 Combination Insulins
1.2.6 Biosimilar Insulins
1.3 Human Insulin Drugs Segment by Application
1.3.1 Global Human Insulin Drugs Sales Comparison by Application: (2022-2028)
1.3.2 Hospital
1.3.3 Household
1.4 Global Human Insulin Drugs Market Size Estimates and Forecasts
1.4.1 Global Human Insulin Drugs Revenue 2017-2028
1.4.2 Global Human Insulin Drugs Sales 2017-2028
1.4.3 Human Insulin Drugs Market Size by Region: 2017 Versus 2021 Versus 2028
2 Human Insulin Drugs Market Competition by Manufacturers
2.1 Global Human Insulin Drugs Sales Market Share by Manufacturers (2017-2022)
2.2 Global Human Insulin Drugs Revenue Market Share by Manufacturers (2017-2022)
2.3 Global Human Insulin Drugs Average Price by Manufacturers (2017-2022)
2.4 Manufacturers Human Insulin Drugs Manufacturing Sites, Area Served, Product Type
2.5 Human Insulin Drugs Market Competitive Situation and Trends
2.5.1 Human Insulin Drugs Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Human Insulin Drugs Players Market Share by Revenue
2.5.3 Global Human Insulin Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Human Insulin Drugs Retrospective Market Scenario by Region
3.1 Global Human Insulin Drugs Retrospective Market Scenario in Sales by Region: 2017-2022
3.2 Global Human Insulin Drugs Retrospective Market Scenario in Revenue by Region: 2017-2022
3.3 North America Human Insulin Drugs Market Facts & Figures by Country
3.3.1 North America Human Insulin Drugs Sales by Country
3.3.2 North America Human Insulin Drugs Revenue by Country
3.3.3 United States
3.3.4 Canada
3.4 Europe Human Insulin Drugs Market Facts & Figures by Country
3.4.1 Europe Human Insulin Drugs Sales by Country
3.4.2 Europe Human Insulin Drugs Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Human Insulin Drugs Market Facts & Figures by Region
3.5.1 Asia Pacific Human Insulin Drugs Sales by Region
3.5.2 Asia Pacific Human Insulin Drugs Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 China Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.6 Latin America Human Insulin Drugs Market Facts & Figures by Country
3.6.1 Latin America Human Insulin Drugs Sales by Country
3.6.2 Latin America Human Insulin Drugs Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.6.6 Colombia
3.7 Middle East and Africa Human Insulin Drugs Market Facts & Figures by Country
3.7.1 Middle East and Africa Human Insulin Drugs Sales by Country
3.7.2 Middle East and Africa Human Insulin Drugs Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Human Insulin Drugs Historic Market Analysis by Type
4.1 Global Human Insulin Drugs Sales Market Share by Type (2017-2022)
4.2 Global Human Insulin Drugs Revenue Market Share by Type (2017-2022)
4.3 Global Human Insulin Drugs Price by Type (2017-2022)
5 Global Human Insulin Drugs Historic Market Analysis by Application
5.1 Global Human Insulin Drugs Sales Market Share by Application (2017-2022)
5.2 Global Human Insulin Drugs Revenue Market Share by Application (2017-2022)
5.3 Global Human Insulin Drugs Price by Application (2017-2022)
6 Key Companies Profiled
6.1 Novo Nordisk
6.1.1 Novo Nordisk Corporation Information
6.1.2 Novo Nordisk Description and Business Overview
6.1.3 Novo Nordisk Human Insulin Drugs Sales, Revenue and Gross Margin (2017-2022)
6.1.4 Novo Nordisk Human Insulin Drugs Product Portfolio
6.1.5 Novo Nordisk Recent Developments/Updates
6.2 Sanofi
6.2.1 Sanofi Corporation Information
6.2.2 Sanofi Description and Business Overview
6.2.3 Sanofi Human Insulin Drugs Sales, Revenue and Gross Margin (2017-2022)
6.2.4 Sanofi Human Insulin Drugs Product Portfolio
6.2.5 Sanofi Recent Developments/Updates
6.3 Eli Lilly
6.3.1 Eli Lilly Corporation Information
6.3.2 Eli Lilly Description and Business Overview
6.3.3 Eli Lilly Human Insulin Drugs Sales, Revenue and Gross Margin (2017-2022)
6.3.4 Eli Lilly Human Insulin Drugs Product Portfolio
6.3.5 Eli Lilly Recent Developments/Updates
6.4 Biocon
6.4.1 Biocon Corporation Information
6.4.2 Biocon Description and Business Overview
6.4.3 Biocon Human Insulin Drugs Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Biocon Human Insulin Drugs Product Portfolio
6.4.5 Biocon Recent Developments/Updates
6.5 Pfizer
6.5.1 Pfizer Corporation Information
6.5.2 Pfizer Description and Business Overview
6.5.3 Pfizer Human Insulin Drugs Sales, Revenue and Gross Margin (2017-2022)
6.5.4 Pfizer Human Insulin Drugs Product Portfolio
6.5.5 Pfizer Recent Developments/Updates
6.6 Wockhardt
6.6.1 Wockhardt Corporation Information
6.6.2 Wockhardt Description and Business Overview
6.6.3 Wockhardt Human Insulin Drugs Sales, Revenue and Gross Margin (2017-2022)
6.6.4 Wockhardt Human Insulin Drugs Product Portfolio
6.6.5 Wockhardt Recent Developments/Updates
6.7 Julphar
6.6.1 Julphar Corporation Information
6.6.2 Julphar Description and Business Overview
6.6.3 Julphar Human Insulin Drugs Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Julphar Human Insulin Drugs Product Portfolio
6.7.5 Julphar Recent Developments/Updates
6.8 Exir
6.8.1 Exir Corporation Information
6.8.2 Exir Description and Business Overview
6.8.3 Exir Human Insulin Drugs Sales, Revenue and Gross Margin (2017-2022)
6.8.4 Exir Human Insulin Drugs Product Portfolio
6.8.5 Exir Recent Developments/Updates
6.9 Sedico
6.9.1 Sedico Corporation Information
6.9.2 Sedico Description and Business Overview
6.9.3 Sedico Human Insulin Drugs Sales, Revenue and Gross Margin (2017-2022)
6.9.4 Sedico Human Insulin Drugs Product Portfolio
6.9.5 Sedico Recent Developments/Updates
7 Human Insulin Drugs Manufacturing Cost Analysis
7.1 Human Insulin Drugs Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Human Insulin Drugs
7.4 Human Insulin Drugs Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Human Insulin Drugs Distributors List
8.3 Human Insulin Drugs Customers
9 Human Insulin Drugs Market Dynamics
9.1 Human Insulin Drugs Industry Trends
9.2 Human Insulin Drugs Market Drivers
9.3 Human Insulin Drugs Market Challenges
9.4 Human Insulin Drugs Market Restraints
10 Global Market Forecast
10.1 Human Insulin Drugs Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Human Insulin Drugs by Type (2023-2028)
10.1.2 Global Forecasted Revenue of Human Insulin Drugs by Type (2023-2028)
10.2 Human Insulin Drugs Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Human Insulin Drugs by Application (2023-2028)
10.2.2 Global Forecasted Revenue of Human Insulin Drugs by Application (2023-2028)
10.3 Human Insulin Drugs Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Human Insulin Drugs by Region (2023-2028)
10.3.2 Global Forecasted Revenue of Human Insulin Drugs by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer

List of Tables

List of Tables
Table 1. Global Human Insulin Drugs Sales Growth Rate Comparison by Type (2022-2028) & (K Units) & (US$ Million)
Table 2. Global Human Insulin Drugs Sales Growth Rate Comparison by Application (2022-2028) & (K Units) & (US$ Million)
Table 3. Global Human Insulin Drugs Market Size by Region (US$ Million) (2017 VS 2021 VS 2028)
Table 4. Global Human Insulin Drugs Market Competitive Situation by Manufacturers in 2021
Table 5. Global Human Insulin Drugs Sales (K Units) of Key Manufacturers (2017-2022)
Table 6. Global Human Insulin Drugs Sales Market Share by Manufacturers (2017-2022)
Table 7. Global Human Insulin Drugs Revenue (US$ Million) by Manufacturers (2017-2022)
Table 8. Global Human Insulin Drugs Revenue Share by Manufacturers (2017-2022)
Table 9. Global Market Human Insulin Drugs Average Price (US$/Unit) of Key Manufacturers (2017-2022)
Table 10. Manufacturers Human Insulin Drugs Manufacturing Sites and Area Served
Table 11. Manufacturers Human Insulin Drugs Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Human Insulin Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Human Insulin Drugs as of 2021)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Human Insulin Drugs Sales by Region (2017-2022) & (K Units)
Table 16. Global Human Insulin Drugs Sales Market Share by Region (2017-2022)
Table 17. Global Human Insulin Drugs Revenue by Region (2017-2022) & (US$ Million)
Table 18. Global Human Insulin Drugs Revenue Market Share by Region (2017-2022)
Table 19. North America Human Insulin Drugs Sales by Country (2017-2022) & (K Units)
Table 20. North America Human Insulin Drugs Sales Market Share by Country (2017-2022)
Table 21. North America Human Insulin Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 22. North America Human Insulin Drugs Revenue Market Share by Country (2017-2022)
Table 23. Europe Human Insulin Drugs Sales by Country (2017-2022) & (K Units)
Table 24. Europe Human Insulin Drugs Sales Market Share by Country (2017-2022)
Table 25. Europe Human Insulin Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 26. Europe Human Insulin Drugs Revenue Market Share by Country (2017-2022)
Table 27. Asia Pacific Human Insulin Drugs Sales by Region (2017-2022) & (K Units)
Table 28. Asia Pacific Human Insulin Drugs Sales Market Share by Region (2017-2022)
Table 29. Asia Pacific Human Insulin Drugs Revenue by Region (2017-2022) & (US$ Million)
Table 30. Asia Pacific Human Insulin Drugs Revenue Market Share by Region (2017-2022)
Table 31. Latin America Human Insulin Drugs Sales by Country (2017-2022) & (K Units)
Table 32. Latin America Human Insulin Drugs Sales Market Share by Country (2017-2022)
Table 33. Latin America Human Insulin Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 34. Latin America Human Insulin Drugs Revenue Market Share by Country (2017-2022)
Table 35. Middle East and Africa Human Insulin Drugs Sales by Country (2017-2022) & (K Units)
Table 36. Middle East and Africa Human Insulin Drugs Sales Market Share by Country (2017-2022)
Table 37. Middle East and Africa Human Insulin Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 38. Middle East and Africa Human Insulin Drugs Revenue Market Share by Country (2017-2022)
Table 39. Global Human Insulin Drugs Sales by Type (2017-2022) & (K Units)
Table 40. Global Human Insulin Drugs Sales Market Share by Type (2017-2022)
Table 41. Global Human Insulin Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 42. Global Human Insulin Drugs Revenue Share by Type (2017-2022)
Table 43. Global Human Insulin Drugs Price by Type (2017-2022) & (US$/Unit)
Table 44. Global Human Insulin Drugs Sales (K Units) by Application (2017-2022)
Table 45. Global Human Insulin Drugs Sales Market Share by Application (2017-2022)
Table 46. Global Human Insulin Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 47. Global Human Insulin Drugs Revenue Share by Application (2017-2022)
Table 48. Global Human Insulin Drugs Price by Application (2017-2022) & (US$/Unit)
Table 49. Novo Nordisk Corporation Information
Table 50. Novo Nordisk Description and Business Overview
Table 51. Novo Nordisk Human Insulin Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 52. Novo Nordisk Human Insulin Drugs Product
Table 53. Novo Nordisk Recent Developments/Updates
Table 54. Sanofi Corporation Information
Table 55. Sanofi Description and Business Overview
Table 56. Sanofi Human Insulin Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 57. Sanofi Human Insulin Drugs Product
Table 58. Sanofi Recent Developments/Updates
Table 59. Eli Lilly Corporation Information
Table 60. Eli Lilly Description and Business Overview
Table 61. Eli Lilly Human Insulin Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 62. Eli Lilly Human Insulin Drugs Product
Table 63. Eli Lilly Recent Developments/Updates
Table 64. Biocon Corporation Information
Table 65. Biocon Description and Business Overview
Table 66. Biocon Human Insulin Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 67. Biocon Human Insulin Drugs Product
Table 68. Biocon Recent Developments/Updates
Table 69. Pfizer Corporation Information
Table 70. Pfizer Description and Business Overview
Table 71. Pfizer Human Insulin Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 72. Pfizer Human Insulin Drugs Product
Table 73. Pfizer Recent Developments/Updates
Table 74. Wockhardt Corporation Information
Table 75. Wockhardt Description and Business Overview
Table 76. Wockhardt Human Insulin Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 77. Wockhardt Human Insulin Drugs Product
Table 78. Wockhardt Recent Developments/Updates
Table 79. Julphar Corporation Information
Table 80. Julphar Description and Business Overview
Table 81. Julphar Human Insulin Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 82. Julphar Human Insulin Drugs Product
Table 83. Julphar Recent Developments/Updates
Table 84. Exir Corporation Information
Table 85. Exir Description and Business Overview
Table 86. Exir Human Insulin Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 87. Exir Human Insulin Drugs Product
Table 88. Exir Recent Developments/Updates
Table 89. Sedico Corporation Information
Table 90. Sedico Description and Business Overview
Table 91. Sedico Human Insulin Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 92. Sedico Human Insulin Drugs Product
Table 93. Sedico Recent Developments/Updates
Table 94. Production Base and Market Concentration Rate of Raw Material
Table 95. Key Suppliers of Raw Materials
Table 96. Human Insulin Drugs Distributors List
Table 97. Human Insulin Drugs Customers List
Table 98. Human Insulin Drugs Market Trends
Table 99. Human Insulin Drugs Market Drivers
Table 100. Human Insulin Drugs Market Challenges
Table 101. Human Insulin Drugs Market Restraints
Table 102. Global Human Insulin Drugs Sales Forecast by Type (2023-2028) & (K Units)
Table 103. Global Human Insulin Drugs Sales Market Share Forecast by Type (2023-2028)
Table 104. Global Human Insulin Drugs Revenue Forecast by Type (2023-2028) & (US$ Million)
Table 105. Global Human Insulin Drugs Revenue Market Share Forecast by Type (2023-2028)
Table 106. Global Human Insulin Drugs Sales Forecast by Application (2023-2028) & (K Units)
Table 107. Global Human Insulin Drugs Sales Market Share Forecast by Application (2023-2028)
Table 108. Global Human Insulin Drugs Revenue Forecast by Application (2023-2028) & (US$ Million)
Table 109. Global Human Insulin Drugs Revenue Market Share Forecast by Application (2023-2028)
Table 110. Global Human Insulin Drugs Sales Forecast by Region (2023-2028) & (K Units)
Table 111. Global Human Insulin Drugs Sales Market Share Forecast by Region (2023-2028)
Table 112. Global Human Insulin Drugs Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 113. Global Human Insulin Drugs Revenue Market Share Forecast by Region (2023-2028)
Table 114. Research Programs/Design for This Report
Table 115. Key Data Information from Secondary Sources
Table 116. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Human Insulin Drugs
Figure 2. Global Human Insulin Drugs Market Share by Type in 2021 & 2028
Figure 3. Basal or Long-acting Insulins Product Picture
Figure 4. Bolus or Fast-acting Insulins Product Picture
Figure 5. Traditional Human Insulins Product Picture
Figure 6. Combination Insulins Product Picture
Figure 7. Biosimilar Insulins Product Picture
Figure 8. Global Human Insulin Drugs Market Share by Application in 2021 & 2028
Figure 9. Hospital
Figure 10. Household
Figure 11. Global Human Insulin Drugs Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 12. Global Human Insulin Drugs Market Size (2017-2028) & (US$ Million)
Figure 13. Global Human Insulin Drugs Sales (2017-2028) & (K Units)
Figure 14. Human Insulin Drugs Sales Share by Manufacturers in 2021
Figure 15. Global Human Insulin Drugs Revenue Share by Manufacturers in 2021
Figure 16. The Global 5 and 10 Largest Human Insulin Drugs Players: Market Share by Revenue in 2021
Figure 17. Human Insulin Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 18. Global Human Insulin Drugs Sales Market Share by Region (2017-2022)
Figure 19. Global Human Insulin Drugs Sales Market Share by Region in 2021
Figure 20. Global Human Insulin Drugs Revenue Market Share by Region (2017-2022)
Figure 21. Global Human Insulin Drugs Revenue Market Share by Region in 2021
Figure 22. United States Human Insulin Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 23. Canada Human Insulin Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 24. Germany Human Insulin Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 25. France Human Insulin Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 26. U.K. Human Insulin Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 27. Italy Human Insulin Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 28. Russia Human Insulin Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 29. China Human Insulin Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 30. Japan Human Insulin Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 31. South Korea Human Insulin Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 32. India Human Insulin Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 33. Australia Human Insulin Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 34. China Taiwan Human Insulin Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 35. Indonesia Human Insulin Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 36. Thailand Human Insulin Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 37. Malaysia Human Insulin Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 38. Mexico Human Insulin Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 39. Brazil Human Insulin Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 40. Argentina Human Insulin Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 41. Colombia Human Insulin Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 42. Turkey Human Insulin Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 43. Saudi Arabia Human Insulin Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 44. UAE Human Insulin Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 45. Sales Market Share of Human Insulin Drugs by Type (2017-2022)
Figure 46. Manufacturing Cost Structure of Human Insulin Drugs
Figure 47. Manufacturing Process Analysis of Human Insulin Drugs
Figure 48. Human Insulin Drugs Industrial Chain Analysis
Figure 49. Channels of Distribution
Figure 50. Distributors Profiles
Figure 51. Bottom-up and Top-down Approaches for This Report
Figure 52. Data Triangulation
Figure 53. Key Executives Interviewed